Patent application number | Description | Published |
20090143329 | GIP SECRETION INHIBITOR - The present invention provides a postprandial GIP secretion inhibitor comprising potassium alginate as an active ingredient. The postprandial GIP secretion inhibitor of the present invention is useful as a medicine or a food product. The present invention also provides use of potassium alginate for the manufacture of a postprandial GIP secretion inhibitor. The present invention also provides a method for inhibiting postprandial GIP secretion, which comprises administering potassium alginate to a subject in need thereof or causing a subject in need thereof to consume potassium alginate. | 06-04-2009 |
20090202704 | POSTPRANDIAL HYPERGLYCEMIA-IMPROVING AGENT - The present invention provides a postprandial hyperglycemia-improving agent, which is useful as a food or a pharmaceutical product. The postprandial hyperglycemia-improving agent includes, as an active ingredient, a fat and oil composition containing 5% by mass or more of a diglyceride and/or a monoglyceride in which an ω9 unsaturated fatty acid content in constituent fatty acids is 35% by mass or more. | 08-13-2009 |
20100022014 | Method for Evaluating Obesity Controller - A method for efficiently evaluating or selecting an obesity controlling substance, a blood insulin regulating substance or a blood sugar regulating substance, is provided. A method for evaluating or screening an obesity controller, the method including administering a carbohydrate and a lipid to an animal, and evaluating or selecting a substance which decreases or increases insulin secretion, is also provided. | 01-28-2010 |
20100209550 | PET FOOD - The present invention relates to pet foods containing carbohydrates that include high-amylose starch, and an animal or vegetable protein. They are excellent in benefits such as having an anti-obesity effect and do not impair the pet's appetite or food intake. | 08-19-2010 |
20110098245 | AGENT FOR PREVENTING OR AMELIORATING OBESITY - The present invention provides a method for preventing or ameliorating obesity, for inhibiting accumulation of visceral fat, for inhibiting accumulation of liver lipid, for preventing or ameliorating fatty liver, including using a material for a pharmaceutical product or food, which has inhibitory actions on body weight increase, accumulation of visceral fat and accumulation of liver lipid. The present invention is also directed to a method for preventing or ameliorating obesity, a method for inhibiting accumulation of visceral fat, a method for inhibiting accumulation of liver lipid, and a method for preventing or ameliorating fatty liver, which methods include administering potassium alginate to a subject in need thereof or having the subject take potassium alginate. | 04-28-2011 |
20110268826 | GIP-Increase Inhibitor - A GIP-increase inhibitor, which is useful as a drug or a food, comprising a rice bran extract as an active ingredient. | 11-03-2011 |
20110275605 | Postprandial Hyperglycemia-Improving Agent - A postprandial hyperglycemia-improving agent, the agent is highly safe and exhibits excellent effects of inhibiting the postprandial increase of blood glucose. The postprandial hyperglycemia-improving agent comprises a cycloartenol or a derivative thereof as an active ingredient. | 11-10-2011 |
20120115779 | AGENT FOR SUPPRESSING ELEVATION OF BLOOD TRIGLYCERIDE CONCENTRATION - An agent for suppressing elevation of a blood triglyceride concentration, comprising a polyglutamic acid as an active ingredient. | 05-10-2012 |
20120122772 | Agent for Suppressing Elevation of Blood GIP Concentration - An agent for suppressing elevation of blood GIP concentration and an agent for preventing or improving obesity, each of which contains a polyglutamic acid as an active ingredient. | 05-17-2012 |